In the same vein, similar rates of surgical site infections were found in patients with prior anti-TNF therapy exposure (12.4% vs. 11.5%, p = 0.692) or detectable drug concentrations (10.3% vs. 12.1%, p = 0.513). Here, TNF is linked to infection.